Brief: Neurometrix Announces Strategic Launch Of Quell Fibromyalgia
03/11/2022 14:09
Nov 3 (Reuters) - NeuroMetrix Inc NURO.O :
* NEUROMETRIX ANNOUNCES STRATEGIC LAUNCH OF QUELL
FIBROMYALGIA
* NEUROMETRIX INC - PATHFINDER STARTS ON DECEMBER 1, 2022
AND WILL
BE LIMITED TO 25 KEY-OPINION LEADERS IN FIBROMYALGIA PRACTICE
ACROSS UNITED STATES
Source text for Eikon: ID:nGNXbZPsTj
Further company coverage: NURO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuroMetrix
See all newsBrief: Neurometrix To Be Acquired By Electrocore
Brief: Neurometrix Reiterates Its Review Of Strategic Alternatives
Brief: NeuroMetrix Announces Steps Taken To Enhance Shareholder Value
Brief: Ephraim Fields Reports 9.3% Stake In Neurometrix, Inc. As Of Feb 23, 2024 - SEC Filing
Brief: RS Fund Reports 14.4% Stake In Neurometrix Inc As Of Feb 13